Home LiteratureArticle Details
PMID: 25416499 Published · epublish English Journal Article Research Support, Non-U.S. Gov't

Selective reporting bias of harm outcomes within studies: findings from a cohort of systematic reviews.

BMJ (Clinical research ed.) ·Vol. 349 ·2014-11-21 ·Pages g6501

Saini P, Loke YK, Gamble C, Altman DG, Williamson PR, Kirkham JJ

Abstract

To determine the extent and nature of selective non-reporting of harm outcomes in clinical studies that were eligible for inclusion in a cohort of systematic reviews. Cohort study of systematic reviews from two databases. Outcome reporting bias in trials for harm outcomes (ORBIT II) in systematic reviews from the Cochrane Library and a separate cohort of systematic reviews of adverse events. 92 systematic reviews of randomised controlled trials and non-randomised studies published in the Cochrane Library between issue 9, 2012 and issue 2, 2013 (Cochrane cohort) and 230 systematic reviews published between 1 January 2007 and 31 December 2011 in other publications, synthesising data on harm outcomes (adverse event cohort). A 13 point classification system for missing outcome data on harm was developed and applied to the studies. 86% (79/92) of reviews in the Cochrane cohort did not include full data from the main harm outcome of interest of each review for all of the eligible studies included within that review; 76% (173/230) for the adverse event cohort. Overall, the single primary harm outcome was inadequately reported in 76% (705/931) of the studies included in the 92 reviews from the Cochrane cohort and not reported in 47% (4159/8837) of the 230 reviews in the adverse event cohort. In a sample of primary studies not reporting on the single primary harm outcome in the review, scrutiny of the study publication revealed that outcome reporting bias was suspected in nearly two thirds (63%, 248/393). The number of reviews suspected of outcome reporting bias as a result of missing or partially reported harm related outcomes from at least one eligible study is high. The declaration of important harms and the quality of the reporting of harm outcomes must be improved in both primary studies and systematic reviews.

MeSH Terms
Cohort Studies Data Collection Drug-Related Side Effects and Adverse Reactions Humans Outcome and Process Assessment, Health Care Publishing Randomized Controlled Trials as Topic Research Design Review Literature as Topic Selection Bias Treatment Outcome
Authors & Affiliations
6 authors, click to expand affiliations / ORCID
Saini Pooja
Department of Public Health and Policy, University of Liverpool, Liverpool, UK.
Loke Yoon K
Norwich Medical School, University of East Anglia, Norwich, UK.
Gamble Carrol
Department of Biostatistics, University of Liverpool, Liverpool, L69 3GA, UK.
Altman Douglas G
Centre for Statistics in Medicine, University of Oxford, Oxford, UK.
Williamson Paula R
Department of Biostatistics, University of Liverpool, Liverpool, L69 3GA, UK.
Kirkham Jamie J
Department of Biostatistics, University of Liverpool, Liverpool, L69 3GA, UK jjk@liv.ac.uk.
References (14)
14 references, click to expand
  1. Quality of reporting in systematic reviews of adverse events: systematic review.
    BMJ. 2014;348:f7668 PMID: 24401468
  2. GRADE guidelines: 5. Rating the quality of evidence--publication bias.
    J Clin Epidemiol. 2011 Dec;64(12):1277-82 PMID: 21802904
  3. Some improvements are apparent in identifying adverse effects in systematic reviews from 1994 to 2011.
    J Clin Epidemiol. 2013 Mar;66(3):253-60 PMID: 23347849
  4. Frequency and reasons for outcome reporting bias in clinical trials: interviews with trialists.
    BMJ. 2011;342:c7153 PMID: 21212122
  5. Outcome reporting bias in randomized trials funded by the Canadian Institutes of Health Research.
    CMAJ. 2004 Sep 28;171(7):735-40 PMID: 15451835
  6. Comparison of search strategies in systematic reviews of adverse effects to other systematic reviews.
    Health Info Libr J. 2014 Jun;31(2):92-105 PMID: 24754741
  7. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies.
    Ann Intern Med. 2007 Oct 16;147(8):573-7 PMID: 17938396
  8. Reporting of harms in randomized controlled trials of psychological interventions for mental and behavioral disorders: a review of current practice.
    Contemp Clin Trials. 2014 May;38(1):1-8 PMID: 24607768
  9. Endorsement of the CONSORT Statement by high impact factor medical journals: a survey of journal editors and journal 'Instructions to Authors'.
    Trials. 2008 Apr 18;9:20 PMID: 18423021
  10. The impact of outcome reporting bias in randomised controlled trials on a cohort of systematic reviews.
    BMJ. 2010;340:c365 PMID: 20156912
  11. Reporting of harms data in RCTs: a systematic review of empirical assessments against the CONSORT harms extension.
    BMJ Open. 2013 Sep 27;3(9):e003436 PMID: 24078752
  12. Availability of large-scale evidence on specific harms from systematic reviews of randomized trials.
    Am J Med. 2004 Oct 15;117(8):582-9 PMID: 15465507
  13. Reporting of adverse events in systematic reviews can be improved: survey results.
    J Clin Epidemiol. 2008 Jun;61(6):597-602 PMID: 18411039
  14. Better reporting of harms in randomized trials: an extension of the CONSORT statement.
    Ann Intern Med. 2004 Nov 16;141(10):781-8 PMID: 15545678
Article Info
Journal
BMJ (Clinical research ed.)
Abbr.
BMJ
ISSN
1756-1833
Published
2014-11-21
Epub
2014-00-21
Pages
g6501
Language
English
Region
England
NLM ID
8900488
PMCID
PMC4240443
Subset
IM
Grants
Cancer Research UK · C5529 · United Kingdom
Medical Research Council · MR/J004855/1 · United Kingdom
Corrections
CommentIn
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com